Influence of age on tobramycin pharmacokinetics in patients with normal renal function
- PMID: 7325627
- PMCID: PMC181756
- DOI: 10.1128/AAC.20.5.587
Influence of age on tobramycin pharmacokinetics in patients with normal renal function
Abstract
The influence of age on tobramycin half-life, volume of distribution, and clearance was examined in 77 patients with infections due to gram-negative bacteria. All patients had normal renal function and hematocrits, were within 20% of their ideal body weight, did not receive penicillin antibiotics concurrently, and had a fever. Twenty-five patients were between 20 and 39 years of age, 23 patients were 40 to 59 years old, and 29 patients were in the age group 60 to 79 years. The mean half-lives were 2.3, 2.2, and 2.4 h, respectively, for the three age groupings. The average clearance and volume of distribution terms were, respectively, 1.34 ml/min per kg and 0.25 liter/kg for the younger group, 1.44 ml/min per kg and 0.26 liter/kg for the middle age group, and 1.25 ml/min per kg and 0.25 liter/kg for the older group. There was no significant difference among the three groups for any of the parameters (P less than 0.05, analysis of variance). Correlation coefficients determined from individual plots of the three pharmacokinetic parameters versus age revealed no correlation between any parameter and age. Forty-five percent of the patients required doses greater than the recommended maximum (5 mg/kg per day) to achieve desired steady-state concentrations. Since tobramycin pharmacokinetics do not change as age increased, doses do not need to be arbitrarily changed in older patients with normal renal function.
Similar articles
-
Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.Eur J Clin Pharmacol. 1983;24(5):639-42. doi: 10.1007/BF00542214. Eur J Clin Pharmacol. 1983. PMID: 6873143
-
Tobramycin sulfate elimination in premature infants.J Pediatr. 1983 Jul;103(1):131-5. doi: 10.1016/s0022-3476(83)80799-9. J Pediatr. 1983. PMID: 6864378
-
Systematically individualizing tobramycin dosage regimens.J Clin Pharmacol. 1980 Oct;20(10):570-80. doi: 10.1002/j.1552-4604.1980.tb01672.x. J Clin Pharmacol. 1980. PMID: 7440765
-
Aspects of the pharmacology and toxicology of tobramycin in animals and humans.J Infect Dis. 1976 Aug;134 Suppl:S97-103. doi: 10.1093/infdis/134.supplement_1.s97. J Infect Dis. 1976. PMID: 787452 Review.
-
Antimicrobial therapy and the neonate.Obstet Gynecol. 1981 Nov;58(5 Suppl):85S-94S. Obstet Gynecol. 1981. PMID: 7031545 Review.
Cited by
-
Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.Drugs Aging. 1997 Apr;10(4):259-77. doi: 10.2165/00002512-199710040-00003. Drugs Aging. 1997. PMID: 9108987 Review.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.
-
Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.Eur J Clin Pharmacol. 1983;24(5):639-42. doi: 10.1007/BF00542214. Eur J Clin Pharmacol. 1983. PMID: 6873143
-
Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet. 1987 Oct;13(4):228-53. doi: 10.2165/00003088-198713040-00002. Clin Pharmacokinet. 1987. PMID: 3311531 Review.
-
Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.Antimicrob Agents Chemother. 1985 Mar;27(3):285-90. doi: 10.1128/AAC.27.3.285. Antimicrob Agents Chemother. 1985. PMID: 3994344 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical